https://www.selleckchem.com/pr....oducts/piperaquine-p
The clinical spectrum of COVID-19 is variable and ranges from asymptomatic, mildly symptomatic, moderately severe and severe disease. A small proportion might develop severe disease and may have cytokine storm. One of the therapeutic options to treat such cases is Tocilizumab (TCZ). In this study, we present cases of severe COVID-19 treated with TCZ and glucocorticoids and discuss the treatment responses. This is a retrospective observational study of severe COVID-19 cases treated with TCZ and glucocorticoids. The case ser
Like
Comment
Share
